Answer
Menveo is contraindicated in people with hypersensitivity to its active substance, any excipient or diphtheria toxoid (CRM₁₉₇), or a life-threatening reaction after previous administration of a vaccine containing similar components.
Sources for this answer
- Menveo Group A,C,W135 and Y conjugate vaccineGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 16Document updated
Sources checked